<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27934956</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>Dec</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies.</ArticleTitle><Pagination><StartPage>38874</StartPage><MedlinePgn>38874</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">38874</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep38874</ELocationID><Abstract><AbstractText>Maternal antibodies transported across the placenta can provide vital immunity against infectious pathogens for infants. We here examine maternal antibody (MA) levels and their association with neonatal antibody levels. Pregnant women of gestational age &#x2265;35 weeks were enrolled at a Guangzhou China hospital and mother-infant paired sera were collected. Measles IgG antibody was detected using ELISA assay, neutralizing antibodies titers against coxsackievirus A16 (CA16), enterovirus 71 (EV71), PV I-III and HIV-1 were performed. 711 mother-infant pairs were enrolled and positive relationships for paired serums were found (r: 0.683-0.918). 81.6%, 87.0%, and 82.3% of mothers, and 87.3%, 72.7%, and 72.2% of newborns were positive for measles, CA16 and EV71 antibodies respectively. The highest Neonatal: maternal ratio (NMR) was found in measles (1.042) and the ratios for the other pathogens ranged from 0.84 to 1.00. Linear regressions showed that log(NMR) decreased by a factor of 0.04-15.43 as log(MA) levels increased. A second analysis restricted to maternal positive measles sera revealed that MA measles of was still inversely associated with NMR. Low NMR was found in high MA HIV&#x2009;+&#x2009;serums among 22 paired sera. MA levels appear to play a role determining transplacental antibody transfer; further study is needed to reveal the mechanism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Chuanxi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Guangzhou Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Liwan District Maternal and Child Health Hospital, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Guangzhou Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yimin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangzhou Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>College for Public Health and Social Justice, Saint Louis University, Saint Louis, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Qiongying</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Guangzhou Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Guangzhou Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhicong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Guangzhou Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guangzhou Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 GM110748</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007112" MajorTopicYN="N">Immunity, Maternally-Acquired</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008459" MajorTopicYN="N">Measles virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010920" MajorTopicYN="N">Placenta</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27934956</ArticleId><ArticleId IdType="pmc">PMC5146964</ArticleId><ArticleId IdType="doi">10.1038/srep38874</ArticleId><ArticleId IdType="pii">srep38874</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brambell F. W. The transmission of immunity from mother to young and the catabolism of immunoglobulins. Lancet 2, 1087&#x2013;1093 (1966).</Citation><ArticleIdList><ArticleId IdType="pubmed">4162525</ArticleId></ArticleIdList></Reference><Reference><Citation>Roopenian D. C. &amp; Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7, 715&#x2013;725, doi: 10.1038/nri2155 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2155</ArticleId><ArticleId IdType="pubmed">17703228</ArticleId></ArticleIdList></Reference><Reference><Citation>Morphis L. G. &amp; Gitlin D. Maturation of the maternofoetal transport system for human gamma-globulin in the mouse. Nature 228, 573 (1970).</Citation><ArticleIdList><ArticleId IdType="pubmed">5528694</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinkernagel R. M. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 345, 1331&#x2013;1335, doi: 10.1056/NEJMra012493 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra012493</ArticleId><ArticleId IdType="pubmed">11794153</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators G. B. D. C. M. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980&#x2013;2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1725&#x2013;1774, doi: 10.1016/S0140-6736(16)31575-6 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31575-6</ArticleId><ArticleId IdType="pmc">PMC5224696</ArticleId><ArticleId IdType="pubmed">27733285</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuridan E. et al.. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 340, c1626, doi: 10.1136/bmj.c1626 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c1626</ArticleId><ArticleId IdType="pubmed">20483946</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W. J. et al.. Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis 14, 308&#x2013;318, doi: 10.1016/S1473-3099(13)70342-6 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray C. J. et al.. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990&#x2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 1005&#x2013;1070, doi: 10.1016/S0140-6736(14)60844-8 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60844-8</ArticleId><ArticleId IdType="pmc">PMC4202387</ArticleId><ArticleId IdType="pubmed">25059949</ArticleId></ArticleIdList></Reference><Reference><Citation>Booy R. &amp; Tashani M. Edging ever closer to polio eradication. Lancet Glob Health 4, e592&#x2013;593, doi: 10.1016/S2214-109X(16)30172-3 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(16)30172-3</ArticleId><ArticleId IdType="pubmed">27539797</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg J. P., Westerbeek E. A., van der Klis F. R., Berbers G. A. &amp; van Elburg R. M. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev 87, 67&#x2013;72, doi: 10.1016/j.earlhumdev.2010.11.003 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2010.11.003</ArticleId><ArticleId IdType="pubmed">21123010</ArticleId></ArticleIdList></Reference><Reference><Citation>Linder N. et al.. Placental transfer of maternal rubella antibodies to full-term and preterm infants. Infection 27, 203&#x2013;207 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10378133</ArticleId></ArticleIdList></Reference><Reference><Citation>Glick C., Feldman S., Norris M. R. &amp; Butler J. Measles, mumps, and rubella serology in premature infants weighing less than 1,000 grams. Southern Med J 91, 159&#x2013;160 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9496869</ArticleId></ArticleIdList></Reference><Reference><Citation>Matys K. et al.. Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine. Clin Vaccine Immunol 19, 881&#x2013;885, doi: 10.1128/CVI.00002-12 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00002-12</ArticleId><ArticleId IdType="pmc">PMC3370453</ArticleId><ArticleId IdType="pubmed">22518014</ArticleId></ArticleIdList></Reference><Reference><Citation>Linder N. et al.. Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status. Vaccine 22, 1509&#x2013;1514, doi: 10.1016/j.vaccine.2003.10.009 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2003.10.009</ArticleId><ArticleId IdType="pubmed">15063576</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S. et al.. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis 191, 1854&#x2013;1860, doi: 10.1086/429963 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/429963</ArticleId><ArticleId IdType="pubmed">15871118</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoko B. J. et al.. The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population. J Infect Dis 184, 627&#x2013;632, doi: 10.1086/322808 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/322808</ArticleId><ArticleId IdType="pubmed">11494168</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu C. X. et al.. Low measles seropositivity rate among children and young adults: A sero-epidemiological study in southern China in 2008. Vaccine 28, 8219&#x2013;8223, doi: 10.1016/j.vaccine.2010.07.071 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.07.071</ArticleId><ArticleId IdType="pubmed">20688039</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F. C. et al.. Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their Infants. Plos One 7, doi: ARTN e37206 10.1371/journal.pone.0037206 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037206</ArticleId><ArticleId IdType="pmc">PMC3360679</ArticleId><ArticleId IdType="pubmed">22662137</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S. T. et al.. Enterovirus 71 Maternal Antibodies in Infants,Taiwan. Emerg Infect Dis 15, 581&#x2013;584, doi: 10.3201/eid1504.081550 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1504.081550</ArticleId><ArticleId IdType="pmc">PMC2671432</ArticleId><ArticleId IdType="pubmed">19331737</ArticleId></ArticleIdList></Reference><Reference><Citation>Black F. L. et al.. Geographic-Variation in Infant Loss of Maternal Measles Antibody and in Prevalence of Rubella Antibody. Am J Epidemiol 124, 442&#x2013;452 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3740044</ArticleId></ArticleIdList></Reference><Reference><Citation>Omenda, M M. et al.. Evidence for Efficient Vertical Transfer of Maternal HIV-1 Envelope-Specific Neutralizing Antibodies but No Association of Such Antibodies With Reduced Infant Infection. Jaids-J Acq Imm Def 64, 163&#x2013;166 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805370</ArticleId><ArticleId IdType="pubmed">23774880</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves G. et al.. Transplacental transfer of measles and total IgG. Epidemiol Infect 122, 273&#x2013;279, doi: 10.1017/S0950268899002046 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268899002046</ArticleId><ArticleId IdType="pmc">PMC2809616</ArticleId><ArticleId IdType="pubmed">10355792</ArticleId></ArticleIdList></Reference><Reference><Citation>Coe C. L., Lubach G. R. &amp; Izard K. M. Progressive Improvement in the Transfer of Maternal Antibody across the Order Primates. Am J Primatol 32, 51&#x2013;55, doi: 10.1002/ajp.1350320106 (1994).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajp.1350320106</ArticleId><ArticleId IdType="pubmed">31936907</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes R. J. Methods for assessing whether change depends on initial value. Stat Med 7, 915&#x2013;927 (1988).</Citation><ArticleIdList><ArticleId IdType="pubmed">3175391</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G. Z. et al.. [Levels of transition on maternal transferred measles antibody in infants in 3 cities in China]. Zhonghua Liu Xing Bing Xue Za Zhi 29, 1074&#x2013;1077 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19173926</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdijk P. et al.. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: A phase I trial in healthy adults. Vaccine 31, 5531&#x2013;5536, doi: 10.1016/j.vaccine.2013.09.021 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.09.021</ArticleId><ArticleId IdType="pubmed">24063976</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C. et al.. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013. BMC Infect Dis 15, 23, doi: 10.1186/s12879-015-0752-z (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0752-z</ArticleId><ArticleId IdType="pmc">PMC4307911</ArticleId><ArticleId IdType="pubmed">25608672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardemil C. V. et al.. Poliovirus Immunity Among Pregnant Females Aged 15&#x2013;44 Years, Namibia, 2010. Journal of Infectious Diseases 210, S136&#x2013;S142, doi: 10.1093/infdis/jiu086 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu086</ArticleId><ArticleId IdType="pmc">PMC6546099</ArticleId><ArticleId IdType="pubmed">25316828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C. H. et al.. Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. J Microbiol Immunol Infect 44, 265&#x2013;273, doi: 10.1016/j.jmii.2011.01.029 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.01.029</ArticleId><ArticleId IdType="pubmed">21524954</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L. Y. et al.. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 291, 222&#x2013;227, doi: 10.1001/jama.291.2.222 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.2.222</ArticleId><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>